Website profile

Indian Pharma Post

Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com

  • 190articles · 30d
  • 10+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 89%with images
  • 244avg words
articles per day
Categories
  • Medical 137
  • Health & Wellness 101
  • Economy, Business & Finance 83
  • Health 74
  • Business & Industrial 68
  • Finance & Business 35
  • Science & Technology 21
  • News 14
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
indianpharmapost.com > news > parag-desai-appointed-head-of-marketing-excellence-at-alembic-pharma-21823

Parag Desai appointed Head of Marketing Excellence at Alembic Pharma

11+ hour, 25+ min ago   (208+ words) Parag Desai has been appointed Head of Marketing Excellence at Alembic Pharmaceuticals Limited, taking on a strategic leadership role focused on strengthening marketing effectiveness, business productivity and strategic execution. Prior to joining Alembic Pharmaceuticals in his new role, Desai served…...

@pharma_indian
indianpharmapost.com > policy > indian-pharmacopoeia-commission-organizes-national-conference-on-quality-and-safety-of-biosimilars-21816

Indian Pharmacopoeia Commission organizes national conference on quality and safety of biosimilars

1+ day, 13+ hour ago   (95+ words) The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a two-day National Conference on “Quality and Safety of Biosimilars: Strengthening India’s Biopharma SHAKTI Vision” on September 10–11, 2026, at the Centre…...

@pharma_indian
indianpharmapost.com > people > bhushan-malpure-elevated-to-head-of-marketing-at-cipla-21817

Bhushan Malpure elevated to Head of Marketing at Cipla

1+ day, 12+ hour ago   (189+ words) Malpure comes with over 17 years of experience in pharmaceutical product management and marketing Bhushan Malpure has been elevated to Head of Marketing at Cipla, marking another step in his pharmaceutical marketing career with the company. Malpure has held several key…...

@pharma_indian
indianpharmapost.com > news > shilpa-medicare-to-launch-shilpa-cdmo-brand-at-cphi-milan-21779

Shilpa Medicare to launch Shilpa CDMO brand at CPHI Milan

4+ day, 11+ hour ago   (553+ words) The new entity focused on development and commercial manufacturing services for complex molecules will operate separately from its parent company’s corporate identity Shilpa Medicare is set to launch Shilpa CDMO, a dedicated contract development and manufacturing organisation focused on complex…...

@pharma_indian
indianpharmapost.com > people > neurizon-appoints-dr-chris-bremer-as-ceo-21768

Neurizon appoints Dr. Chris Bremer as CEO

5+ day, 4+ hour ago   (277+ words) Neurizon Therapeutics has appointed Dr. Chris Bremer as Chief Executive Officer, effective October 1, 2026 while the Australian biotechnology company advances its lead ALS drug candidate NUZ-001. Dr. Bremer will initially serve as CEO and will not join the board of Neurizon…...

@pharma_indian
indianpharmapost.com > biopharma > indian-immunologicals-seeks-probe-into-nsq-abhayrab-vials-says-samples-differ-from-genuine-batch-21739

Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch

1+ week, 1+ hour ago   (329+ words) Indian Immunologicals Limited (IIL) has clarified that the Abhayrab vaccine samples recently found to be Not of Standard Quality (NSQ) and misbranded were not manufactured by its vaccine division, Human Biologicals Institute (HBI). The clarification follows an enforcement action by the…...

@pharma_indian
indianpharmapost.com > biopharma > indian-immunologicals-denies-manufacturing-low-quality-abhayrab-vials-found-in-delhi-seeks-probe-21739

Indian Immunologicals denies manufacturing low quality Abhayrab vials found in Delhi, seeks probe

1+ week, 10+ hour ago   (325+ words) Indian Immunologicals Limited (IIL) has clarified that the Abhayrab vaccine samples recently found to be Not of Standard Quality (NSQ) and misbranded were not manufactured by its vaccine division, Human Biologicals Institute (HBI). The clarification follows an enforcement action by the…...

@pharma_indian
indianpharmapost.com > news > dadachanji-group-launches-kaisha-pharma-with-45-million-investment-21725

Dadachanji Group launches KAISHA Pharma with €45 million Investment

1+ week, 1+ day ago   (202+ words) The Dadachanji Group, whose promoters built pharmaceutical glass-packaging company Schott Kaisha before exiting the venture in 2021, has launched KAISHA Pharma, marking its return to the segment with an initial investment of €45 million as it targets Indian and global pharmaceutical and…...

@pharma_indian
indianpharmapost.com > interviews > we-recently-launched-aminosaaya-system-in-india-dr-purushottam-sutar-product-business-development-manager-south-asia-hitachi-high-tech-india-72

We recently launched AminoSAAYA System in India: Dr. Purushottam Sutar, Product & Business Development Manager - South Asia, Hitachi High-Tech India

2+ week, 30+ min ago   (55+ words) Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches 12 reference standards to strengthen quality of phytopharma Cipla’s InvaGen plant in New York gets VAI status from…...

@pharma_indian
indianpharmapost.com > news > astrazeneca-india-receives-esg-rating-of-57-from-crisil-21542

AstraZeneca India receives ESG rating of 57 from CRISIL

2+ week, 6+ day ago   (335+ words) AstraZeneca Pharma India Limited has received an Environmental, Social and Governance (ESG) rating of 57 from Crisil ESG Ratings & Analytics Limited, based on publicly available information. The company disclosed the rating under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)…...